News | Cardiovascular Education | May 02, 2025

AHA Presents 2025 Paul Dudley White Award to Dr. Christine E. Seidman

Renowned cardiovascular geneticist and Harvard Medical School professor honored for groundbreaking research and lifelong commitment to advancing heart health. Dr. Seidman was featured in a 3-part DAIC video series

Dr. Seidman serves as the Thomas W. Smith Professor of Medicine at Harvard Medical School

Dr. Seidman serves as the Thomas W. Smith Professor of Medicine at Harvard Medical School and director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital


The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician-scientist and pioneer in cardiovascular genetics, has been selected as the recipient of the 2025 Paul Dudley White Award.

The award, established in 1974, is presented annually to a Boston-based medical professional who has made extraordinary contributions to cardiovascular or stroke care. Dr. Seidman was honored at the 2025 Boston Heart and Stroke Ball, April 5, at the Omni Boston Hotel at the Seaport.

A trailblazer in the field of cardiovascular genetics, Dr. Seidman serves as the Thomas W. Smith Professor of Medicine at Harvard Medical School and director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital. Her groundbreaking research has transformed the understanding of inherited heart diseases, leading to revolutionary advances in diagnosis, treatment and prevention. She is the fourth woman to receive the Paul Dudley White Award.

The selection of Dr. Seidman by the Paul Dudley White Award Selection Committee reflects her unparalleled contributions to cardiovascular medicine. Her research has uncovered the genetic causes of hypertrophic cardiomyopathy (HCM), a condition that is the leading cause of sudden cardiac death in young athletes. Her discoveries have enabled early genetic diagnoses, helping families understand their risk and receive appropriate medical care before symptoms develop. Moreover, her work has laid the foundation for innovative precision therapies, including the development of mavacamten, the first FDA-approved targeted treatment for HCM.

Dr. Seidman’s impact extends beyond the laboratory. A dedicated mentor and advocate for diversity in science and medicine, she has trained and inspired generations of young investigators, including many women and individuals from underrepresented backgrounds. Her commitment to fostering the next generation of physician-scientists reflects the values of Dr. Paul Dudley White, a founder of the American Heart Association and a champion of preventive cardiology, who was born in Roxbury and practiced medicine in Boston.

“Dr. Christine Seidman’s contributions have redefined modern cardiovascular genetics and biology, profoundly influencing the way we diagnose and treat inherited heart diseases,” said Karen Whitefield, the American Heart Association’s executive director in Greater Boston. “Her leadership, mentorship, and groundbreaking discoveries exemplify the highest ideals of the American Heart Association’s mission—to be a relentless force for a world of longer, healthier lives.”

Dr. Seidman is the co-director of the Seidman Lab at Harvard Medical School, which she leads alongside her husband, Jonathan G. Seidman. The lab is renowned for its groundbreaking research on the genetic causes of cardiovascular diseases, with a particular focus on inherited heart conditions.

A graduate of Harvard University with a bachelor’s degree in biochemistry, Dr. Seidman earned her medical degree from George Washington University School of Medicine and Health Sciences. She completed her internship and residency at Johns Hopkins Hospital, followed by a fellowship in cardiology at Massachusetts General Hospital and a research fellowship at Harvard Medical School.

Dr. Seidman has authored more than 400 peer-reviewed research articles and has served in editorial roles for leading scientific journals, including the Journal of Clinical InvestigationAmerican Journal of Medical Genetics, and Science. Throughout her career, Dr. Seidman has been recognized with numerous honors from the American Heart Association for her pioneering contributions to cardiovascular research.

For more information about the event or to support the American Heart Association, please visit heart.org/BostonHB.

 

Dr. Seidman was featured in a 3-part DAIC video series 


Related Content

News | AHA

May 8, 2025 — Nancy Brown, chief executive officer of the American Heart Association, has been named to TIME’s 2025 ...

Home May 12, 2025
Home
News | AHA

July 24, 2024 — Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF ...

Home July 24, 2024
Home
News | AHA

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

Home July 09, 2024
Home
News | AHA

July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...

Home July 05, 2024
Home
News | AHA

June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular ...

Home June 18, 2024
Home
News | AHA

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID ...

Home May 24, 2024
Home
News | AHA

February 9, 2024 — Injection of a substance to block an artery feeding the dura (protective sack around the brain) — ...

Home February 09, 2024
Home
News | AHA

February 8, 2024 — The American Heart Association (AHA), currently celebrating its centennial year, announced that it is ...

Home February 08, 2024
Home
News | AHA

February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s ...

Home February 08, 2024
Home
News | AHA

February 7, 2024 — According to results from a multi-center trial in the United States, called Zero Degree Head ...

Home February 07, 2024
Home
Subscribe Now